Trending

Adamis

FDA rejects Adamis opioid overdose therapy Zimhi, hitting share price

FDA rejects Adamis opioid overdose therapy Zimhi, hitting share price

Shares in Adamis Pharmaceuticals have been poleaxed by an FDA decision to reject Zimhi, intended as a treatment

X

FDA rejects Adamis opioid overdose therapy Zimhi, hitting share price

https://pharmaphorum.com/news/fda-rejects-adamis-opioid-overdose-therapy-zimhi-hitting-share-price/

FDA approves Adamis’ cheaper rival to EpiPen

FDA approves Adamis’ cheaper rival to EpiPen

Symjepi also smaller and more convenient.

X

FDA approves Adamis’ cheaper rival to EpiPen

https://pharmaphorum.com/news/adamis-mylan-epipen/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com